NCT02424474View on ClinicalTrials.gov

T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients

NACompletedINTERVENTIONAL
Enrollment

933

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

February 14, 2017

Conditions
Trisomy 21, 18 and 13 Screening
Interventions
DEVICE

Genetic NIPT

Both tests are realized in a population of pregnant women (with and without in vitro fertilisation (IVF)) concomitantly at the same time.

BIOLOGICAL

Regular serum screening

Trial Locations (1)

92141

AP-HP, Antoine Béclère Hospital, Clamart

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02424474 - T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients | Biotech Hunter | Biotech Hunter